ArticlePloS one2025
A hybrid approach to enhance HbA1c prediction accuracy while minimizing the number of associated predictors: A case-control study in Saudi Arabia.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Developing count regression techniques for predicting the number of new type 2 diabetes cases in Saudi Arabia.PloS one · 2026Article
- Ensemble neural network modelling for stratified HbA1c prediction: Integrating past glucose measurement as a predictor of glycaemic control.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 2 diabetes (T2D) is considered a significant global health concern. Hemoglobin A1c level (HbA1c) is recognized as the most reliable indicator for its diagnosis. Genetic, family, environmental, and health behaviors are the factors associated with the disease. T2D is linked to substantial economic costs and human suffering, making it a primary concern for health planners, physicians, and those living with the disease. Saudi Arabia currently ranks seventh worldwide in terms of prevalence rate. Despite this high rate, the country lacks focused research on T2D. This study aims to develop hybrid prediction models that integrate the strengths of multiple algorithms to enhance HbA1c prediction accuracy while minimising the number of significant Key Performance Indicators (KPIs). The proposed model can help healthcare practitioners diagnose T2D at an early stage. Analyses were conducted in a case-control study in Saudi Arabia involving cases (patients with HbA1c levels ≥ 6.5) and controls with normal HbA1c levels (< 6.5). Medical records from 3,000 King Abdulaziz University Hospital patients containing demographic, lifestyle, and lipid profile data were used to develop the models. For the first time, we utilized recommended machine learning algorithms to develop hybrid prediction models to reduce the number of significant KPIs while enhancing HbA1c prediction accuracy. The hybrid model combining Random Forest (RF) and Logistic Regression (LR) with only 4 out of 10 KPIs outperformed other models with an accuracy of 0.93, precision of 0.95, recall of 0.90, F-score of 0.92, an AUC of 0.88, and Gini index of 0.76. The significant variables identified by the model through backward elimination are age, body mass index (BMI), triglycerides (TG), and high-density lipoprotein (HDL). The proposed model helps healthcare providers identify patients at risk of T2D by monitoring fewer key predictors of HbA1c levels, enhancing early intervention strategies for managing diabetes in Saudi Arabia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.